维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Boschelli"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Bosutinib:A review of preclinical studies in chronic myelogenous leukaemia显示文摘	Boschelli F Arndt K Gambacorti-Passerini C	2010	EurJCancer2010，46，10：	1
2	Optimization of 4- phenylamino-3-quinolineearbonitriles as potent inhibitors of sre kinase activity 显示文摘	BOSCHELLI D H YE F WANG Y D	2001	J Med Chem2001，44，23：	1
3	Second generation 4-(4-methyl-I H- indol-5-ylamino )-2-phenyhhieno pyridine-5-carbonitrile PKCtheta inhibitors 显示文摘	Wu B Boschelli DH Lee J	2009	Bioorg Med Chem I~tt2009，19，3：	1
4	Pyridopyrimidin-7-one Inhibitors of cyclin-dependent kinases显示文摘	MARK BARVIAN DIANE H BOSCHELLI	2000	Journal of Medicinal Chemistry2000，43，24：	1
5	In vitro and invivo activity of SKI-606, a novel Src-Abl inhibitor, againstimatinib-resistant Bcr-Abl+ neoplastic cells显示文摘	Puttini M Coiluccia AM Boschelli F	2006	Cancer Res2006，66，11：	1
6	4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermalgrowth factor receptor kinase and their bioisostericrelationship to the 4-anilino-6,7-dialkoxyquinazolineinhibitors 显示文摘	Wissner A Berger DM Boschelli DH	2000	J Med Chem2000，43，：	1
7	Bosutinib : a review of preclinical studies in chronic myelogenous leukaemia显示文摘	BOSCHELLI F ARNDT K GAMBACORTI- PASSERIN1 C	2010	Eur J Cancer2010，46，10：	1
8	Optimization of 5-vinylaryl-3- pyridinecarbonitriles as PKC theta inhibitors 显示文摘	Boschelli DH Subrath J Niu C	2010	Bioorg Med Chem Lett2010，20，6：	1
9	Optimization of4-phenylamino-3-quinolinecarbonitriles as potent inhibitorsof Src kinase activity 显示文摘	Boschelli DH Ye F Wang YD	2001	J Med Chem2001，44，23：	1
10	Bo- sutinib: a review of preelinieal studies in chronic myelogenousleukaemia 显示文摘	BOSCHELLI F ARNDT K GAMBACORTI-PASSERINI C	2010	Eur J Cancer2010，，：	1
11	4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermalgrowth factor receptor kinase and their bioisostericrelationship to the 4-anilino-6,7-dialkoxyquinazolineinhibitors 显示文摘	Wissner A Berger DM Boschelli DH	2000	J Med Chem2000，43，：	1
12	Bosutinib: a review of preclinical studies in chronic myelogenous leukaemia 显示文摘	Boschelli F Amdt K Gambacorti-Passerini C	2010	Er J Cancer2010，46，10：	1
13	Optimization of4-phenylamino-3-quinolinecarbonitriles as potent inhibitorsof Src kinase activity 显示文摘	Boschelli DH Ye F Wang YD	2001	J Med Chem2001，44，23：	1
14	Identification of 7-phenylaminothieno-pyridine-6-carbonitriles as a new class of Src kinase inhibitors显示文摘	Boschelli D H Wu B Q Sosa A C B	2004	J Med Chem2004，47，27：	1
15	Bosutinib:A review of preclinieal studies in chronic mye显示文摘	Boschelli F Arndt K Gambacorti-Passerini C	2010	Eur J Cancer2010，46，10：	1
16	Synthesis and anti-rumor activities of a novel series of tricyclic 1 -anilino-5H-pyridazino indoles显示文摘	WISSNER A BERGER D M BOSCHELLI D H	2000	J Med Chem2000，43，17：	1
17	CDC37 is required for p60v- src activity in yeast显示文摘	Dey B Lightbody J J Boschelli F	1996	Mol Biol Cell1996，7，：	1
18	Inhibition of Src kinase activity by 4-ani- lino-7-thienyl-3-quinolinecarbonitriles显示文摘	Boschelli DH Wang DY	2002	Bioorganic & Medicinal Chemistry Letters2002，12，15：	1
19	Dual inhibitors of src and Abl tyrosine kinases 显示文摘	BOSCHELLI D H	2004	Drug Design Reviews2004，1，3：	1
20	Differential in vivo regulation of steroid hormone receptor activation by Cdc37p显示文摘	Fliss A E Fang Y Boschelli F	1997	Mol Biol Cell1997，8，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示